News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,996 Results
Type
Article (1923)
Company Profile (3)
Press Release (69070)
Section
Business (21481)
Career Advice (9)
Deals (4557)
Drug Development (8163)
FDA (1804)
Job Trends (801)
News (37051)
Policy (3569)
Tag
Academia (93)
Allergies (7)
Alliances (8169)
ALS (9)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (22)
Approvals (1854)
Artificial intelligence (17)
Automation (1)
Bankruptcy (9)
Best Places to Work (585)
Biosimilars (39)
Biotechnology (5)
Bladder cancer (19)
Brain cancer (3)
Breast cancer (30)
Cancer (325)
Cardiovascular disease (8)
Career advice (9)
CAR-T (8)
Cell therapy (35)
Cervical cancer (1)
Clinical research (7190)
Collaboration (150)
Compensation (16)
Complete response letters (3)
COVID-19 (196)
C-suite (36)
Cystic fibrosis (4)
Data (346)
Depression (5)
Diabetes (20)
Diagnostics (639)
Digital health (1)
Drug discovery (19)
Duchenne muscular dystrophy (20)
Earnings (7823)
Events (7157)
Executive appointments (55)
FDA (2057)
Fibrodysplasia Ossificans Progressiva (1)
Funding (87)
Gene editing (3)
Gene therapy (22)
GLP-1 (56)
Government (233)
Grass and pollen (1)
Guidances (33)
Healthcare (1078)
HIV (1)
Huntington's disease (1)
IgA nephropathy (11)
Immunology and inflammation (4)
Indications (7)
Infectious disease (204)
Inflammatory bowel disease (19)
Influenza (7)
Intellectual property (21)
IPO (1638)
Job creations (241)
Job search strategy (9)
Layoffs (7)
Legal (953)
Liver cancer (17)
Lung cancer (62)
Lymphoma (24)
Manufacturing (47)
MASH (9)
Medical device (1134)
Medtech (1136)
Mergers & acquisitions (3049)
Metabolic disorders (51)
Multiple sclerosis (11)
NASH (1)
Neurodegenerative disease (9)
Neuroscience (209)
NextGen: Class of 2025 (220)
Non-profit (62)
Obesity (19)
Opinion (1)
Ovarian cancer (15)
Pain (5)
Pancreatic cancer (10)
Parkinson's disease (23)
Partnered (2)
Patents (35)
Patient recruitment (19)
People (5022)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1947)
Phase II (3024)
Phase III (2717)
Pipeline (247)
Policy (1)
Postmarket research (241)
Preclinical (678)
Press Release (2)
Prostate cancer (9)
Radiopharmaceuticals (22)
Rare diseases (35)
Real estate (601)
Regulatory (2696)
Reports (6)
Research institute (94)
RNA editing (1)
RSV (1)
Schizophrenia (10)
Series A (18)
Series B (14)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (8)
Vaccines (32)
Venture capital (2)
Weight loss (3)
Women's health (2)
Date
Today (10)
Last 7 days (51)
Last 30 days (229)
Last 365 days (2716)
2025 (1849)
2024 (3257)
2023 (3836)
2022 (7033)
2021 (6386)
2020 (5875)
2019 (3863)
2018 (3010)
2017 (3560)
2016 (3172)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (83)
Alabama (3)
Arizona (9)
Asia (21647)
Australia (2441)
California (489)
Canada (297)
China (254)
Colorado (4)
Connecticut (18)
Delaware (4)
Europe (12769)
Florida (43)
Georgia (11)
Illinois (22)
India (19)
Indiana (8)
Japan (136)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (94)
Massachusetts (344)
Michigan (4)
Minnesota (31)
Missouri (3)
Nebraska (1)
Nevada (3)
New Jersey (280)
New York (187)
North Carolina (72)
Northern California (190)
Ohio (3)
Oregon (1)
Pennsylvania (82)
South America (107)
Southern California (231)
Tennessee (1)
Texas (44)
United States (1817)
Utah (13)
Virginia (36)
Washington D.C. (3)
Washington State (25)
Wisconsin (6)
70,996 Results for "lumiradx ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care
July 29, 2024
·
4 min read
Genetown
LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests
LumiraDx Limited announced that it signed a commercial distribution agreement with Axon Lab AG for the commercialization of its LumiraDx Platform and diagnostic tests to include exclusive distribution rights in Switzerland and additional non-exclusive distribution rights in further European countries to include and starting in Germany.
July 31, 2023
·
6 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Genetown
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
LumiraDx Limited, a next generation point of care diagnostics company, announced the appointment of joint administrators for two of its subsidiaries.
December 29, 2023
·
5 min read
Press Releases
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
August 28, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September 2025
August 25, 2025
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results
August 19, 2025
·
2 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.
September 4, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
August 15, 2025
·
18 min read
1 of 7,100
Next
